2022
DOI: 10.1007/s12032-022-01907-5
|View full text |Cite
|
Sign up to set email alerts
|

Fibronectin type III domain-containing protein 5 promotes autophagy via the AMPK/mTOR signaling pathway in hepatocellular carcinoma cells, contributing to nab-paclitaxel chemoresistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 49 publications
0
2
0
Order By: Relevance
“…It was recently shown that overexpression of FNDC5 in cultured human cells can up-regulate autophagic flux ( 27 ). Consistent with this, we found that overexpression of mouse FNDC5, as well as Idit, could up-regulate autophagic flux in human embryonic kidney 293 (HEK293) cells ( SI Appendix , Fig.…”
Section: Resultsmentioning
confidence: 99%
“…It was recently shown that overexpression of FNDC5 in cultured human cells can up-regulate autophagic flux ( 27 ). Consistent with this, we found that overexpression of mouse FNDC5, as well as Idit, could up-regulate autophagic flux in human embryonic kidney 293 (HEK293) cells ( SI Appendix , Fig.…”
Section: Resultsmentioning
confidence: 99%
“…FNDC5 expression levels in various cancers are not consistent. FNDC5 is upregulated in human tissues of breast cancer (Cebulski et al, 2022), ovarian cancer (Zhu et al, 2022) and hepatocellular carcinoma (Zhou et al, 2022), but downregulated in human osteosarcoma tissues (Cheng et al, 2020a). In the present study, FNDC5 expression was increased in human cervical adenocarcinoma, squamous cell carcinoma or adenosquamous carcinoma as well as two human CxCa cell lines.…”
Section: Discussionmentioning
confidence: 99%